| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Co-chief Executive Officer | Chief Commercial Officer
4 companies
Glickman Mark A serves as a Chief Commercial Officer at ESPR and has filed Form 4s across 4 companies. Across recent SEC filings that breaks down to 0 buys and 1 sell. Those positions are worth an estimated $6K at current prices.
The biggest single holding is TXMD (~$6K) as Co-chief Executive Officer. The recent filings there lean toward selling, a net 440 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2022 | TXMD Therapeuticsmd, Inc. | Co-chief Executive Officer | Sale+OE | 440 | $4.92 | $2,165.46 | -25.4% | -12.0% | -58.4% |